Skip to main content

Market Overview

Johnson & Johnson Reportedly Settles California Talc Case Midtrial

Share:
Johnson & Johnson Reportedly Settles California Talc Case Midtrial

Johnson & Johnson (NYSE: JNJ) has settled its California talc case midtrial and is likely to avoid a huge judgement, according to Law 360.

Alameda County Superior Court Judge Stephen Kaus in Oakland, California reportedly made the announcement to the jury today.

Johnson & Johnson has faced more than 14,000 claims that its talc powder caused ovarian cancer and mesothelioma, a rare cancer linked to asbestos exposure.

In December, a jury in Los Angeles sided with the company in the case of Amy Fong, who alleged Johnson & Johnson’s talc contained asbestos and caused her to develop mesothelioma, reports the Fierce Pharma.

Johnson & Johnson shares were down 0.49% at $143.59 at the time of publication. The stock has a 52-week high of $148.99 and a 52-week low of $121.

Related Links:

Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder

Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements

Public domain photo via Wikimedia

 

Related Articles (JNJ)

View Comments and Join the Discussion!

Posted-In: Law 360News Legal Media Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com